All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @teebzfx on TikTok · 59s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @teebzfx's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Testosterone levels have finally come back in and it's not looking good.
  2. 0:03So I've got low testosterone, 14.7 which is below average. The average or good test level is clearly 18 to 25.
  3. 0:10Sex drive, boom in through the roof.
  4. 0:12Don't know how to pronounce this, albumin.
  5. 0:15That is basically your gut and liver which produces protein.
  6. 0:19That is extremely high. Proteins coming into the body nicely.
  7. 0:22However, the free testosterone in my body is super low.
  8. 0:25This is to do a muscle building, brain fog, libido, all of that kind of stuff.
  9. 0:30So that's super low as well. So I've got a few things to work on.
  10. 0:32Now the company I've done this with is called Manual.
  11. 0:34The second I brought it and done the testosterone results and sent them off.
  12. 0:38They instantly try up-salamite a package, right?
  13. 0:41Which is now 90 pound and I need to do this package to potentially go on TRT.
  14. 0:45So I'm a little bit skeptical to know whether this is actually true or not.
  15. 0:48So what I've done is I've phoned up my GP and I'm going to try and get bloodworks done,
  16. 0:52chat a little bit of crap to them to make sure I can get in there.
  17. 0:54So then I'll put my GP's blood results on here and let's see if this company's real or not.

@teebzfx's testosterone test claims need more context

TeebzFx

TikTok creator

34.8K viewsWatch on TikTok

Quick answer

The creator reports a total testosterone of 14.7 nmol/L from a direct-to-consumer test, which falls within the lower end of most clinical reference ranges rather than definitively below them. UK clinical guidelines (BSSM) set 12 nmol/L as the threshold for considering treatment, making his result a grey-area finding that warrants proper clinical assessment rather than an immediate TRT upsell. His plan to obtain GP-ordered blood work is the appropriate next step before any clinical decision is made.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @teebzfx's testosterone test claims need more context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@teebzfx's testosterone test claims need more context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@teebzfx's testosterone test claims need more context" from TeebzFx. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator reports a total testosterone of 14.

The reason this review is not generic is the source wording and the canonical claim label "trt low test according to this company getting blood done by gp." In this clip, the useful excerpt is: "Testosterone levels have finally come back in and it's not looking good." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

The Endocrine Society (Bhasin et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator reports a total testosterone of 14.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator reports a total testosterone of 14.7 nmol/L from a direct-to-consumer test, which falls within the lower end of most clinical reference ranges rather than definitively below them. UK clinical guidelines (BSSM) set 12 nmol/L as the threshold for considering treatment, making his result a grey-area finding that warrants proper clinical assessment rather than an immediate TRT upsell. His plan to obtain GP-ordered blood work is the appropriate next step before any clinical decision is made.
  • BSSM and NHS guidelines place the clinical threshold for considering TRT at 12 nmol/L, not 18 nmol/L. A result of 14.7 is not straightforwardly 'low' by these standards.
  • The Endocrine Society (Bhasin et al., 2018) requires at least two separate morning fasting testosterone samples before diagnosing hypogonadism. One home test result is not sufficient.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • BSSM and NHS guidelines place the clinical threshold for considering TRT at 12 nmol/L, not 18 nmol/L. A result of 14.7 is not straightforwardly 'low' by these standards.
  • The Endocrine Society (Bhasin et al., 2018) requires at least two separate morning fasting testosterone samples before diagnosing hypogonadism. One home test result is not sufficient.
  • Testosterone follows a diurnal rhythm and can drop by up to 35% from morning to afternoon. The timing of the sample significantly affects the result.
  • Albumin in a hormone panel is relevant because it binds testosterone and affects free T calculations. It is not a measure of dietary protein intake, contrary to what the video suggests.
  • A 2023 JAMA Internal Medicine commentary by Handelsman identified financial incentives in direct-to-consumer hormone companies as a risk factor for over-diagnosis of low testosterone.
  • Free testosterone is clinically meaningful, but low free T alone is not a diagnosis. It needs to be interpreted alongside SHBG, LH, FSH, and symptom presentation by a qualified clinician.
  • The creator's decision to seek GP-ordered blood work before accepting the company's framing is the right call and aligns with published clinical best practice.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @teebzfx actually say?

The creator got a home testosterone test through a UK company called Manual, received a total testosterone result of 14.7, and was told this is "below average" with a "good" range of 18 to 25. He also flagged that his free testosterone is low and that his albumin is "extremely high." His read on albumin, that it "basically" represents gut and liver protein production, came with some skepticism from him too. Credit where it's due: he didn't just accept the result. He called his GP to get NHS blood work done and plans to compare the two. That's actually the right instinct.

He also flagged that Manual immediately tried to upsell him a 90-pound package once his results came back low. That detail matters, and we'll come back to it.

Does the science back this up?

The numbers here are more nuanced than the video makes them sound. A total testosterone of 14.7 nmol/L is not clearly "low" by most clinical standards. The European Male Ageing Study (Wu et al., 2010, NEJM) and the European Association of Urology guidelines place the lower threshold for symptomatic hypogonadism at around 12 nmol/L, with a grey zone between 8 and 12. The British Society for Sexual Medicine (BSSM) guidelines use 12 nmol/L as their cut-off for considering treatment. At 14.7, he is technically within the lower end of the normal adult male reference range, which most labs set between roughly 8.6 and 29 nmol/L.

Free testosterone matters too. Total testosterone can be misleading if sex hormone-binding globulin (SHBG) is high, which would sequester more testosterone and lower the biologically active fraction. If his free T is genuinely low and his albumin is elevated, that's a clinically relevant picture, but it still needs proper clinical context, not an automated upsell.

What did they get wrong (or right)?

The albumin explanation needs correcting. He said albumin is "basically your gut and liver" and linked it to protein intake. Albumin is a protein produced by the liver, yes, but its relevance in a testosterone panel is different: albumin loosely binds testosterone, and high albumin can actually increase total testosterone while keeping free testosterone lower. It is not a marker of dietary protein intake in this context. That explanation was wrong.

His claim that "the average or good test level is clearly 18 to 25" is also off. That range has no consensus backing in the clinical literature. NHS and BSSM guidelines do not use 18 to 25 nmol/L as a standard. Manual appears to be using its own proprietary "optimal" range, which is a common tactic among direct-to-consumer hormone testing companies. It is not the same as clinical hypogonadism criteria.

What he got right: his skepticism about the upsell is well-founded. Research on direct-to-consumer hormone testing companies, including a 2023 JAMA Internal Medicine commentary by Handelsman, has flagged that financial incentives in these models can drive over-diagnosis of "low T."

What should you actually know?

A single testosterone result from a home test kit is not a diagnosis. The Endocrine Society (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism) recommends that low testosterone be confirmed on at least two separate morning samples before any clinical decision is made. Testosterone levels follow a diurnal rhythm, peaking in the morning and dropping by up to 35% by afternoon. The time of the test matters.

If you genuinely have symptoms, the right path is what this creator is already doing: get NHS or GP-ordered bloods, ideally a morning fasting sample that includes total testosterone, free testosterone, LH, FSH, SHBG, prolactin, and a full blood count. That gives a clinical picture, not just a number a subscription company can act on.

  • TRT is a legitimate treatment for confirmed hypogonadism, but "confirmed" means clinical symptoms plus biochemical evidence, not a single result from a commercial kit.
  • The reference range used by Manual (18 to 25 nmol/L) does not appear in NHS, BSSM, or Endocrine Society guidelines. Understand whose numbers you're looking at.
  • Elevated albumin in a hormone panel does not mean your protein intake is high. It has a specific relevance to how testosterone is bound in your blood.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

TeebzFx · TikTok creator

34.8K views on this video

Low Test According To This Company. Getting Blood Done by GP Next Too See if This Is Real or Fake #testosterone #gym #routine

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about bssm?

BSSM and NHS guidelines place the clinical threshold for considering TRT at 12 nmol/L, not 18 nmol/L. A result of 14.7 is not straightforwardly 'low' by these standards.

What does the video say about the endocrine society (bhasin et al., 2018) requires at least?

The Endocrine Society (Bhasin et al., 2018) requires at least two separate morning fasting testosterone samples before diagnosing hypogonadism. One home test result is not sufficient.

What does the video say about testosterone follows a diurnal rhythm?

Testosterone follows a diurnal rhythm and can drop by up to 35% from morning to afternoon. The timing of the sample significantly affects the result.

What does the video say about albumin in a hormone panel?

Albumin in a hormone panel is relevant because it binds testosterone and affects free T calculations. It is not a measure of dietary protein intake, contrary to what the video suggests.

What does the video say about a 2023 jama internal medicine commentary by handelsman identified financial?

A 2023 JAMA Internal Medicine commentary by Handelsman identified financial incentives in direct-to-consumer hormone companies as a risk factor for over-diagnosis of low testosterone.

What does the video say about free testosterone?

Free testosterone is clinically meaningful, but low free T alone is not a diagnosis. It needs to be interpreted alongside SHBG, LH, FSH, and symptom presentation by a qualified clinician.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by TeebzFx, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.